Welcome to our dedicated page for So-Young Intl news (Ticker: SY), a resource for investors and traders seeking the latest updates and insights on So-Young Intl stock.
So-Young International Inc. (Nasdaq: SY) is described as the leading aesthetic treatment platform in China, connecting consumers with online services and offline treatments. The news flow around SY focuses heavily on quarterly financial and operational updates, corporate actions related to its listing, and developments in its branded aesthetic center network and product activities.
Investors following SY news will see regular unaudited financial results releases furnished on Form 6-K, covering revenue composition across aesthetic treatment services, information and reservation services, sales of medical products and maintenance services, and other services. These announcements also provide detail on cost of revenues, operating expenses, non-GAAP metrics and cash positions, giving readers insight into how So-Young’s business mix is evolving over time.
Operational highlights in So-Young’s news include the number of fully operational branded aesthetic centers in major Chinese cities, verified treatment visits, verified aesthetic treatments performed and active users visiting the centers. The company also discloses information on the number of institutions served with supply chain solutions for injectables and shipment volumes for injectable products such as Elasty, illustrating activity in its upstream product and supply chain segment.
Corporate and capital market updates are another recurring theme in SY news. So-Young has issued press releases on plans and timing for ADS ratio changes, as well as notifications about regaining compliance with Nasdaq’s minimum bid price requirement. The company also announces the filing of its annual report on Form 20-F and provides schedules and dial-in details for earnings conference calls.
For readers and investors, the SY news page offers a centralized view of So-Young’s financial performance, operational metrics, listing-related developments and strategic updates. Monitoring these releases can help track how the company’s aesthetic treatment platform, branded centers and medical aesthetic product activities are progressing over time.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
So-Young International Inc. (NASDAQ: SY) announced the filing of its annual report on Form 20-F for the fiscal year ending December 31, 2022, with the Securities and Exchange Commission on April 25, 2023. The report is accessible on the company’s investor relations website. Shareholders and ADS holders can obtain a hard copy of the annual report, which contains audited financial statements, by request. As a leader in China's medical aesthetics social community, So-Young provides reliable information and vetted services to users, aiming to expand within the medical aesthetic industry and the growing consumption healthcare market.
So-Young International Inc. (Nasdaq: SY) reported unaudited financial results for Q4 and FY 2022, revealing total revenues of RMB325.1 million (US$47.1 million) for Q4, down 27.7% year-over-year. The company achieved a net income of RMB31.3 million (US$4.5 million), reversing a loss of RMB27.7 million in Q4 2021. However, FY 2022 revenues declined 25.7% to RMB1,257.9 million (US$182.4 million), with a net loss of RMB65.6 million (US$9.5 million) compared to a loss of RMB8.4 million in FY 2021. The company holds a solid cash balance of RMB1.6 billion, providing potential growth opportunities in 2023. Looking ahead, So-Young expects Q1 2023 revenues between RMB290 million (US$42.0 million) and RMB310 million (US$44.9 million).